| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 7250% | ₹562.050% | 1,140 | - | - |
| 7,975-8.33% | ₹499.15-1.86% | 1,200 | ₹0.05-80% | 66,700-2.12% |
| - | - | 1,220 | ₹0.350% | 10,1500% |
| - | - | 1,240 | ₹0.05-91.66% | 10,1500% |
| - | - | 1,260 | ₹0.10% | 19,5750% |
| 2,9000% | ₹1700% | 1,280 | ₹0.40% | 4,3500% |
| 15,9500% | ₹399.45-2.13% | 1,300 | ₹0.05-66.66% | 68,1500% |
| 2,1750% | ₹160.90% | 1,320 | ₹0.1550% | 29,725-4.65% |
| 2,900300% | ₹363-0.81% | 1,340 | ₹0.05-66.66% | 52,925-2.66% |
| 7,9750% | ₹149.10% | 1,360 | ₹0.05-50% | 81,9250% |
| 7250% | ₹134.750% | 1,380 | ₹0.150% | 28,2750% |
| 42,050-19.44% | ₹293-5.08% | 1,400 | ₹0.10% | 1,40,650-19.16% |
| 27,550-11.62% | ₹276-3.15% | 1,420 | ₹0.05-66.66% | 39,150-10% |
| 53,650-23.71% | ₹260-2.8% | 1,440 | ₹0.050% | 1,05,125-7.64% |
| 76,125-5.40% | ₹235-2.08% | 1,460 | ₹0.10% | 76,125-22.22% |
| 55,825-4.93% | ₹218.65-4.51% | 1,480 | ₹0.150% | 75,400-8.77% |
| 1,02,950-30.39% | ₹225.359.92% | 1,500 | ₹0.05-66.66% | 2,97,250-12.39% |
| 89,175-4.65% | ₹181.551.99% | 1,520 | ₹0.05-50% | 1,15,275-12.15% |
| 1,39,925-7.21% | ₹153.95-8.33% | 1,540 | ₹0.05-50% | 72,500-35.89% |
| 90,625-13.19% | ₹136-8.1% | 1,560 | ₹0.05-50% | 1,45,725-2.89% |
| 69,600-23.80% | ₹114.6-4.46% | 1,580 | ₹0.150% | 1,15,275-3.63% |
| 1,95,025-24.43% | ₹85.5-20.61% | 1,600 | ₹0.05-75% | 2,34,900-26.36% |
| 73,950-11.30% | ₹75-12.94% | 1,620 | ₹0.05-50% | 2,34,900-3.28% |
| 92,075-16.99% | ₹62-6.34% | 1,640 | ₹0.05-87.5% | 1,48,625-19.29% |
| 74,675-14.16% | ₹34-27.96% | 1,660 | ₹0.05-91.66% | 1,87,050-29.12% |
| 62,350-58.04% | ₹15.65-44.99% | 1,680 | ₹0.05-94.11% | 1,13,825-54.62% |
| 1,16,000-65.06% | ₹0.05-99.5% | 1,700 | ₹11.7397.87% | 1,26,150-69.20% |
| 1,32,675-22.78% | ₹0.05-97.72% | 1,720 | ₹30106.18% | 52,200-14.28% |
| 56,550-49.35% | ₹0.05-94.11% | 1,740 | ₹300% | 1,4500% |
| 38,425-49.03% | ₹0.05-91.66% | 1,760 | - | - |
| 22,475-13.88% | ₹0.05-87.5% | 1,780 | - | - |
| 17,400-48.93% | ₹0.05-75% | 1,800 | - | - |
| 12,325-29.16% | ₹0.050% | 1,840 | - | - |
| 7250% | ₹0.750% | 1,880 | - | - |
Acetylcysteine Injection will be launched in 6 gm/30 mL (200 mg/mL) single-dose vials, and will be made available to hospitals and other system-wide healthcare providers.
The lawsuits included one on a generic version of Zetia, a cholesterol drug, as well as four other lawsuits involving Vytorin, a combination drug that contains Zetia.
EBITDA surged to ₹600.3 crore, up from a loss of ₹208.7 crore in the year-ago quarter, indicating better operational efficiency
It also appropriates ₹5.86 crore that Glenmark had already paid for surrendering IGST refunds relating to non-realisation of export proceeds.
According to a statement from the firm, the Travoprost ophthalmic solution (0.004% ionic buffered solution) is both bioequivalent and therapeutically equivalent to the reference listed medication
The company also reported revenue from operations to ₹3433.7 Crore. The EBITDA margin for the quarter that ended on September 30, 2024 stands at 17.5%.
Glenmark Pharmaceuticals Inc, USA, issued a countrywide (US) Class II recall on September 24 this year.
This positive outcome indicates compliance with FDA standards and enhances Glenmark's credibility in the pharmaceutical sector.
In conclusion, the US Food and Drug Administration (USFDA) has issued Form 483 with no observations.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
